Dr. Litvan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4550 Executive Dr
325
La Jolla, CA 92037
Summary
- Dr. Irene Litvan is a neurologist in San Diego, CA and is affiliated with multiple hospitals in the area, including UC San Diego Medical Center – Hillcrest and VA San Diego Healthcare System. She received her medical degree from Universidad de la República - Facultad de Medicina and has been in practice 38 years. She also speaks multiple languages, including Spanish. She specializes in movement disorder, neurodegenerative, and dementia & geriatrics and is experienced in general neurology, multiple system atrophy, movement disorders, and dementia. She has more than 400 publications and over 60,000 citings.
Education & Training
- MedStar Health/Georgetown University HospitalResidency, Neurology, 1989 - 1992
- Saint Elizabeths Hospital-DC Department of Behavioral HealthInternship, Transitional Year, 1988 - 1989
- Universidad de la República - Facultad de MedicinaClass of 1979
Certifications & Licensure
- CA State Medical License 2011 - 2025
- MD State Medical License 1990 - 2018
- KY State Medical License 2003 - 2014
- IN State Medical License 2005 - 2005
- DC State Medical License 1993 - 2002
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Top 1% of most cited scientific studies worldwide Web of Science, 2018-2022
- Foreign Member of the National Academy of Medicine National Academy of Medicine of Uruguay, 2019
- Movement Disorder Research Award American Academy of Neurology, 2018
- Join now to see all
Clinical Trials
- Risk Factors for Progressive Supranuclear Palsy (PSP) Start of enrollment: 2006 Aug 01
- A Pilot Clinical Trial of Pyruvate, Creatine, and Niacinamide in Progressive Supranuclear Palsy. Start of enrollment: 2004 Apr 01
- Study to Identify Clinical, Imaging and Biologic Markers of Parkinson Disease Progression Start of enrollment: 2010 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- Diagnosing primary lateral sclerosis: a clinico-pathological study.Eva M J de Boer, Bálint S de Vries, Wim Van Hecke, Angelika Mühlebner, Koen L Vincken
Journal of Neurology. 2024-12-12 - Why Crafting a Compelling Abstract Is Important to Summarize Research Findings.Irene Litvan
Movement Disorders Clinical Practice. 2024-12-01 - Clinical validation of a wearable ultrasound sensor of blood pressure.Sai Zhou, Geonho Park, Katherine Longardner, Muyang Lin, Baiyan Qi
Nature Biomedical Engineering. 2024-11-20
Journal Articles
- Tauopathy-Associated PERK Alleles Are Functional Hypomorphs That Increase Neuronal Vulnerability to ER StressShauna H Yuan, Karen Chiang, Irene Litvan, Human Molecular Genetics
- Corticobasal Degeneration with TDP-43 Pathology Presenting with Progressive Supranuclear Palsy Syndrome: A Distinct Clinicopathologic SubtypeJ Eric Ahlskog, Keith A Josephs, Ryan J Uitti, Bradley F Boeve, Irene Litvan, Dennis W Dickson, Acta Neuropathologica
- Diagnostic criteria for the neuropathological assessment of Parkinson diseaseDickson DW, Braak H, Duda, MD J E Duyckaerts C, Gasser T, Halliday GM, Hardy J, Leverenz JB, Del Tredici K, Wszolek ZW, Litvan I.*, Lancet Neurology, 12/1/2009
- Join now to see all
Books/Book Chapters
Lectures
- Shaking out the Subtleties of Parkinson’s – A Program for Primary Care Physicians, Pharmacists & Healthcare ProfessionalsUniversity of California, San Diego, La Jolla, California - 1/31/2013
- Key Note Speaker at the Symposium in Movement DisordersModena, Italy - 1/1/2010
- Key Note Speaker at the 4th Symposium in Parkinson’s disease and related movement disordersPuebla, Mexico - 1/1/2010
Authored Content
- AAN 2021 Study Preview: Effective Tau TherapiesApril 2021
Press Mentions
- New Hope for Progressive Supranuclear Palsy with Innovative TrialSeptember 3rd, 2024
- MJFF Supporting Trial of Retinal Tracer for Parkinson’s DiagnosisOctober 31st, 2022
- CurePSP's Clinical Guide to Rare Neurodegenerative Conditions Is Published by Leading Neurology JournalJuly 1st, 2021
- Join now to see all
Grant Support
- Real-Time L-Dopa Monitoring for Improved Management of ParkinsonNational Institutes of Neurological Disorders and Stroke2020–2023
Professional Memberships
- Member
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: